Marshman Fund Trust II 3
3 · Harmony Biosciences Holdings, Inc. · Filed Aug 18, 2020
Insider Transaction Report
Form 3
Marshman Fund Trust II
10% Owner
Holdings
Series A Preferred Stock
→ Common Stock (3,043,213 underlying)- 6,931,763
Common Stock
Footnotes (1)
- [F1]The Series A Preferred Stock is convertible into Common Stock on a 8.215-for-1 basis into the number of shares of Common Stock as shown in Column 3 at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment or further consideration. These shares have no expiration date.